HAVA
NASDAQ · N/A
Harvard Ave Acquisition-Cl A
$10.12
-0.01 (-0.10%)
Open$10.11
Previous Close$10.13
Day High$10.12
Day Low$10.10
52W High$10.13
52W Low$9.87
Volume—
Avg Volume39.0K
Market Cap209.00M
P/E Ratio110.67
EPS$0.10
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 219.03M | 196.60M | 211.78M |
| Net Income | 8.69M | 7.47M | 7.70M |
| Profit Margin | 4.0% | 3.8% | 3.6% |
| EBITDA | 14.09M | 11.42M | 12.03M |
| Free Cash Flow | 7.43M | 6.90M | 7.76M |
| Rev Growth | +5.0% | -0.4% | +4.7% |
| Debt/Equity | 0.54 | 0.45 | 0.54 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.33 | +0.96% | — | 3.76B |
| PICS | Pics Nv | $11.07 | -1.51% | 6.4 | 1.43B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.20% | 74.9 | 642.73M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.28% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | -0.10% | 57.7 | 594.36M |